+ T cells are primed in the lymph nodes, after which they clonally expand to form a large population of cytotoxic effector cells. After the initial response, most cells are rapidly cleared through apoptosis, but a few memory cells survive. These memory cells have the capacity to expand rapidly upon secondary antigen challenge (1) . Advances in recent years have made it possible to measure a wide variety of surface and intracellular markers, which has led to the characterization of a multitude of functionally distinct CD8 + T cell subsets (2) .
A number of recent studies have described the properties of a new human memory CD8 + T-cell subset characterized by high expression of CD161 and IL-18Rα. The group of Lantz described mucosal-associated invariant T (MAIT) cells, 'innate-like' T lymphocytes characterized by the expression of a semi-invariant TCR Vα7.2-Jα33, which recognize the MHC-related protein 1 (MR1) (3) . MAIT cells can become activated when stimulated with antigen presenting cells that are fed with bacteria and fungi but not with viruses. More recently, Turtle et al. (4) described a CD161 ++ IL-18Rα + memory CD8 + T-cell subset, which based on the expression of the ABC-B1 transporter and c-KIT, resemble hematopoietic stem International Immunology, Vol. 24, No. 10, doi:10.1093/intimm/dxs069 Advance Access publication 26 July 2012 cells (HSC). ABC-B1 transporter expression may endow these cells with resistance to toxic xenobiotics, such as cytostatic drugs (5, 6) . Indeed, they are more likely to be resistant to chemotherapy and may play an important role in the protection against latent viral infections during chemotherapy-induced lymphocytopenia (4, 7) . Because of their resemblances to HSC, these memory CD8 + T cells have been proposed to be a good candidate for a memory 'stem' cell pool, which is able to provide life-long protection without the need to re-encounter antigen (8) (9, 10) . As it was demonstrated that MAIT cells express high levels of the ABC-B1 transporter (10), the MAIT and memory 'stem' cell pool may represent identical or at least overlapping populations.
We question here whether CD161 ++ IL-18Rα + CD8 + T cells have any other stem-cell characteristics. To investigate this, we determined their location and functional properties, including telomere length and telomerase activity.
Materials and methods

Isolation of mononuclear cells from peripheral blood, lymph nodes, bone marrow and lung tissue
Peripheral blood mononuclear cells (PBMCs) were obtained from buffy coats of healthy blood donors, from blood of kidney transplant recipients or from patients undergoing lung surgery. PBMCs were isolated using standard density gradient centrifugation.
Lymph nodes were collected from kidney transplant recipients during donor kidney implantation. Briefly, lymph node mononuclear cells were isolated from surgical residual material (surrounding the external iliac vessels) of the recipient, gathered during the implantation of the transplanted kidney. The residual tissue removed in this procedure often contains lymph nodes. Directly after kidney transplant surgery, the gathered lymph nodes were chopped in small pieces. A cell suspension was obtained by grinding the material through a flow-through chamber.
Peripheral lung tissue was collected from patients who underwent a lobectomy for a peripheral lung tumour. Lung mononuclear cells were isolated from peripheral lung tissue according to the procedure described by Piet et al. (11) .
Bone marrow cells were isolated from bone marrow aspirates obtained from the sternum of patients undergoing cardiac surgery. Bone marrow mononuclear cells were isolated using standard density gradient centrifugation techniques.
Spleen mononuclear cells were isolated from spleen of post-mortal organ donors. The spleen cells were isolated with a cell strainer followed by density gradient centrifugation.
All mononuclear cells gathered were subsequently cryopreserved until the day of analysis.
Where necessary, patients gave written informed consent and the study was approved by the Medical Ethics Committee of the Academic Medical Center in Amsterdam.
Immunofluorescent staining and flow cytometry
PBMCs were washed in PBS containing 0.01% (w/v) NaN 3 and 0.5% (w/v) BSA. For tetramer staining, PBMCs were first incubated with an appropriate concentration of tetrameric complexes in a small volume for 30 min at 4°C, protected from light. Fluorescent-labelled conjugated mAbs were added and incubated for 30 min at 4°C, protected from light at concentrations according to manufacturer's instructions. For surface-marker expression analysis, the following antibodies were used in different combinations: CD161 FITC/PE/APC, CD3 PE-Cy 7, CD4 AF700, CD8 PerCP-Cy5.5 CD45RA PE-Cy7, Granzyme A PE, Perforin PE, CCR5 PE, CXCR3 Alexa 488, CD62L PE, CD24 FITC (BD Biosciences, San Diego, CA, USA), CD45RA PerCP-Cy 5.5, CD3 APC, CD127 PerCP-Cy 5.5, CD3 AF700, IL18-Rα FITC/PE, CD44 APC, CD166 PE (eBioscience Inc, San Diego, USA), CD8 PE AF610, CD27 APC-AF750, Granzyme B PE (Invitrogen, Paisley, UK), Granzyme K FITC (Immunotools, Friesoythe, Germany), CX3CR1 PE (MBL international corporation), CCR7 PerCP-Cy 5.5, CXCR6 AF647 (Biolegend, San Diego, USA), CXCR4 PE, CCR6 FITC (R&D systems, Abingdon, UK), CD133 APC (Miltenyi Biotec, Bergisch Gladbach, Germany) KLRG1 biotin(a gift from Prof. H. Pircher) with GaM APC-Alexa Fluor 750 secondary antibody (Invitrogen). Samples were analysed on a BD FACSCanto using FACSDiva Software. Analysis was done using FlowJo Mac.
Tetramer complexes
The following HLA-peptide tetramer complexes were kindly provided by Anja ten Brinke (Sanquin, Amsterdam, the Netherlands): HLA-A1 tetramer loaded with the CMV pp65-derived YSEHPTFTSQY, HLA-A2 tetramer loaded with the CMV pp65-derived NLVPMVATV peptide, HLA-B7 tetramer loaded with the CMV pp65-derived TPRVTGGGAM peptide, HLA-B35 tetramer loaded with the CMV pp65-derived IPSINVHHY peptide, HLA-A2 tetramer loaded with the CMV IE1-derived VLEETSVML peptide and HLA-A2 tetramer loaded with the FLU-derived GILGFVFTL peptide.
Cell sorting
One day prior to cell sorting, PBMCs were thawed and labelled with CFSE. 
CFSE labeling
PBMCs were pelleted and resuspended in PBS at final concentration of 5-10 10E6 cells/ml. Next, cells were labeled in 0.5 uM (final concentration) of CFSE (Molecular Probes Europe) in PBS for 10 minutes at 37 C. Cells were washed and subsequently resuspended in IMDM (Life Technologies) containing 10% fetal calf serum, 100U ml sodium penicillin 626 Stem cell properties of CD161 ++ CD8 + T cells G (Brocades Pharma BV), 100ug ml streptomycin sulphate (Invitrogen) and 0.0035% 2-ME (Merck).
Stimulation and cell culture
Cells were cultured in IMDM (Life Technologies, Gaithersburg, MD) containing 10% fetal calf serum, 100 U ml −1 sodium penicillin G (Brocades Pharma BV, Leiderdorp, The Netherlands), 100 µg ml −1 streptomycin sulphate (Invitrogen) and 0.0035% 2-ME (Merck). For stimulation, we added soluble 1 µg ml −1 anti-CD3 (clone 1XE, Sanquin, Netherlands) and soluble 5 µg ml −1 anti-CD28 (clone 15E8, Sanquin) to the cell culture in absence or presence of various different cytokines; 50 U ml −1 IL-2 (Biotest Ag, Dreieich, Germany), 10 ng ml − cells were stimulated with irradiated feeder cells in a one-to-one ratio.
Proliferation is expressed in precursor frequency, which was calculated as follows: ∑ ( )
where n is the division number that cells have gone through and P n the number of cells in division n (12).
Luminex
Supernatants were analysed by Bioplex human cytokine 27-plex luminex assay (Bio-Rad) according to manufacturer's instructions.
Telomere length measurement by flow-FISH
Telomere length of CD161 ++ IL-18Ra + and CD161 -IL-18Ra − memory CD8 + T cells was measured using a modified version of the flow-fluorescence in situ hybridization (FISH) method that was previously described (13) . First, cells were stained with mAb to CD3V500, CD8V450, CD161FITC (BD), CD27AF700 (eBioscience), CD45RA-NC605 (Invitrogen). After staining for 30 min, the cells were washed in PBS and fixed in BS3 (final concentration 1 nM) (Pierce, Rockford, USA) for 30 min at 4°C. The reaction was quenched using 1 ml of 50 nM Tris (pH 7.2) in PBS and incubated in the dark for 20 min at room temperature. After being washed with PBS followed by hybridization buffer, cells were incubated in 0.75 µg ml −1 of the telomeric probe conjugated to Cy5 (Cambridge research biochemicals, Cleveland, UK). Samples were then heated for 10 min at 82°C, rapidly cooled, and left to hybridize in the dark at room temperature for 1 h. Samples were washed in post-hybridization buffer followed by PBS and analysed immediately by flow cytometry (Fortessa, BD). All samples were run in triplicate. We calculated fold changes of mean fluorescence intensity (MFI) of the different CD8 + T cell subsets, the MFI of CD27 + CD45RA + naïve T cells was set to 1.
Measurement of telomerase activity
Sorted CD161 ++ IL-18Rα + and CD161 -IL-18Rα − memory CD8 + T cells were stimulated for 7 days with 10 ng ml −1 IL-15, after which 2 × 10E5 cells were snap-frozen. Telomerase activity was determined using the telomeric repeat amplification protocol (TRAP; TRAPeze telomerase detection kit; Serologicals, distributed through Chemicon Europe) as previously described. PCR was performed with samples adjusted to 500 Ki67 + cells per reaction. Ki67 + cells were identified using αKi67 PE Ab (BD) (14) .
Aldehyde dehydrogenase activity
Aldehyde dehydrogenase (ALDH) activity was measured using the commercial reagent ALDEFLUOR (STEM-CELL Technologies Inc, Vancouver, BC, Canada). The ALDEFLUOR substrate (BAAA) is taken up by live cells through passive diffusion, whereupon it is converted in the cytoplasm into a fluorescent molecule (BAA-) under the action of ALDH. In the assay buffer, ABC-transporter inhibitors are present, which prevent active efflux. As a control, ALDH activity was blocked using diethylaminobenzaldehyde (DEAB). Cells with high ALDH activity can be identified by green fluorescence (BAA-) on the flowcytometer.
Quantitative PCR
Total RNA was isolated using a standard RNA isolation kit (Invitek, Berlin, Germany) and reverse transcribed to cDNA using random hexamers and Superscript II reverse transcriptase (Roche Diagnostics). Quantitative PCR was performed using the StepOnePlus RT-PCR system (Applied Biosystems) using Express SYBR GreenER (Invitrogen). Primer sequences are available on request.
Statistical analysis
Statistical analysis of paired samples was done by two-tailed Wilcoxon signed rank test with a 95% confidence interval. Non-paired samples were analysed with two-tailed MannWhitney test with a 95% confidence interval. − memory phenotype (Fig. 1A) . We reasoned that if these cells perform a stem-cell-like function, they may preferentially locate to LN and/or bone marrow. Interestingly, we found that CD161 ++ IL-18Rα + CD8 + T cells were present in the circulation of all adult individuals tested (mean = 6.4% of CD8 + T cells) and that the amount of CD161 ++ IL-18Rα + CD8 + T cells residing in bone marrow and spleen was similar to that found in peripheral blood (Fig. 1B) .
Results
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Strikingly, CD161 ++ IL-18Rα + CD8 + T cells were virtually absent in LN (Fig. 1B and C) . Also in the lung, we observed a low frequency of this population (Fig. 1B and D) .
The absence of CD161 ++ IL-18Rα + CD8 + T cells from LN might be due to specific chemokine receptor expression. Indeed, we found expression of CCR6, CXCR6 and CCR5 but . PBMCs from healthy adults were labelled with antibodies to CCR6, CXCR4, CX3CR1, CXCR3, CCR7, CD62L, CXCR6, CCR5, Granzyme K, B and A and KLRG1. The data are representative for five healthy individuals. Statistically significant differences were determined using Mann-Whitney test (B) and Wilcoxon signed rank test (C and D). * P < 0.05, ***P < 0.005. Fig. 2A) . Apparently, CD161 ++ IL-18Rα + memory CD8 + T cells cannot be activated by a TCR stimulus and costimulation alone, but need a third signal to proliferate. In a transwell system, with a membrane impermeable for cells, we found that cell-cell contact contributes, but was not necessary for CD161 ++ IL-18Rα + memory CD8 + T-cell proliferation (Fig. 2B) . To characterize the cell type that provides the third signal, we added sorted CD4 + T cells, monocytes or a combination of both to the stimulation (Supplementary Figure 1C , available at International Immunology Online.). We found the CD4 + T cells are necessary in order to provided help for the CD161 ++ IL-18Rα + memory CD8 + T cells (Fig. 2C) . Adding B cells alone or in combination with CD4 + T cells and/or monocytes to the stimulation had no effect on proliferation (data not shown). CD4 + T cells might support division by the secretion of cγ cytokines. Indeed, addition of IL-2 in combination with IL-21 to the cultures had the same effect as the addition of CD4 + T cells (Fig. 2D) . Interestingly, the addition of IL-15, IL-12, IL-18 or IL-18 in combination with IL-12, to TCR stimulation and co-stimulation, significantly increased proliferation of CD161 ++ IL-18Rα + CD8 + T cells (Fig. 2E) . IL-15, IL-18 and IL-12 are all cytokines produced by myeloid dendritic cells. Purified myeloid dendritic cells (Lin-, BDCA-1+) did not provide the additional signal, but modestly enhanced the effect of CD4 + T cells (Fig. 2F ). With plasmacytoid dendritic cells (Lin-, BDCA-4+), this additional effect was not seen.
Finally, we used the homeostatic cytokines IL-7 and IL-15 in absence of TCR stimulation. When stimulating CD161 ++ IL-18Rα + memory CD8 + T cells with IL-15 for 7 days we observed significantly more proliferation; a trend which was also seen with IL-7 (Fig. 3G) .
In summary, CD161 ++ IL-18Rα + memory CD8 + T cells do not proliferate upon TCR stimulation and co-stimulation but require an additional signal to proliferate, which can be delivered either by CD4 + T cells, most likely through the production of cγ cytokines, or by the exposure to the T h 1-inducing cytokines IL-12 and IL-18. Fig. 4B and C) . CD161 ++ /IL-18Rα + CD8 + T cells contain granzyme A and granzyme K but no granzyme B (Fig. 1E) , which coincides with their CD27 + CD45RA
− memory phenotype (15) (16) (17) . Furthermore, they express KLRG1 (Fig. 1E) , a marker expressed on antigen-experienced T cells that is described to be a marker for senescence (18) and which might play an inhibitory role (19) .
To analyse the molecular basis for the differentiation state of the CD161 ++ IL-18Rα + CD8 + cells, we investigated the expression of the key transcription factors Blimp-1, T-bet, Eomes and ZNF683, which are known to be differentially, regulated between memory and effector cells (20, 21) . We observed significantly more Blimp-1 to be expressed on CD161
++ IL-18Rα + memory CD8 + T cells than CD161 -IL-18Rα − cells (Fig. 5A) . T-bet and Eomes were expressed equally on both subsets (Fig. 5B and C) . ZNF683 was not expressed at all in the CD161 ++ IL-18Rα + memory CD8 + T cells (Fig. 5D) .
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++ CD8 + T cells 629 On the Y-axis, the proliferation rate is expressed in precursor frequency. Statistically significant differences were determined by the Mann-Whitney test. *P < 0.05, **P < 0.01, ***P < 0.005, ns = difference is not significant. To analyse telomere length, we performed a FACS-based in situ hybridization technique. Despite the comprehensive hybridization protocol, we were still able to distinguish CD161 ++ memory CD8 + T cells from the CD161 -memory CD8 + T cells (Fig. 6A ). We calculated a relative telomere length of the different CD8 + T cell subsets as fold change compared with the naïve CD8 + T cells. As expected, naïve CD8 + T cells had the highest mean fluorescent intensity for the telomere Cy5 probe, meaning the longest telomere length, followed by memory cells and subsequently the effector cells with the shortest telomere length (Fig. 6B and C) . CD161 ++ memory CD8 + T cells consistently had a shorter relative telomere length than the CD161 -memory CD8 + T cells (P = 0.02) (Fig. 6B and C) .
Using the TRAP assay, telomerase activity was studied after 7 days of stimulation with IL-15. We observed that upon stimulation with IL-15, CD161 ++ IL-18Rα + memory CD8 + T cells had 
T cells do not express ALDH
ALDHs are a family of enzymes involved in detoxifying a wide variety of aldehydes (23) . ALDH was first recognized as a marker for HSC and is currently also used as a marker for cancer stem cells (24) . To investigate whether CD161 ++ IL-18Rα + memory CD8 + T cells express ALDH, we performed the ALDEFLUOR assay. Within the total PBMC fraction, we were able to detect a small population of ALDH positive cells (Fig. 7A ), but we did not observe any ALDH positive cells within the CD161 ++ IL-18Rα + memory CD8 + T cells (Fig. 7B) . As a control, we added diethylaminobenzaldehyde (DEAB), which blocks the ALDH activity.
In conclusion, CD161 ++ IL-18Rα + memory CD8 + T cells are not able to detoxify aldehydes using ALDH, again lacking similarity with classical stem cells.
Discussion
CD161 ++
IL-18Rα
+ memory CD8 + T cells form a distinct subset of CD8 + T cells that resemble HSC by over-expressing the ABC-B1 transporter and cKit (4) . Apart from these two features, we did not identify any other characteristics that mark these cells as stem cells. Rather, our data suggest that this population mainly contains T h 1 cytokine-producing memory-type cells with very stringent activation requirements that, based on chemokine receptor expression, have the ability to migrate to inflamed tissue.
We showed that CD161 ++ IL-18Rα + memory CD8 + T cells reside in peripheral blood, bone marrow and spleen, but significantly less in lymph nodes. Dusseaux et al. have demonstrated that they are present in significant numbers in intestinal tissue and that their presence is even higher in the liver (10 (25) (26) (27) . The ABC-B1 transporter may be highly relevant for the functioning of these cells at these sites as it can actively protect these cells against toxic substances they encounter in the liver, gut and at sites of inflammation.
Contradictory reports have been published regarding the pathogen specificity of CD161 ++ IL-18Rα + CD8 + T cells (3, 4, 10, 28 
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++ CD8 + T cells 633 (30) , indicating that they indeed may have a long replicative history. Increased telomere erosion has previously been found in the highly differentiated CD28 − CD8 + T cells (31, 32) and progressive reduction in telomere length occurs in the differentiation of naïve cells to memory to effector T cells (33) . In addition, we showed that CD161 ++ IL-18Rα + memory CD8 + T cells express KLRG1 and that they express significantly more BLIMP-1 than the 'classical' memory CD8 + T cells. KLRG1 is a cell-surface marker known to identify antigen-experienced T cells with reduced proliferative capacity and may play an inhibitory role in human T cells (19) . KLRG1-expressing cells are largely CD28 − but there is also a small group of CD28 + CD8 + T cells that express KLRG1 (18) . BLIMP-1 is also preferentially expressed in terminally differentiated effector-type CD8 + T cells and is important for maintenance of homeostasis, preventing the accumulation of activated cells (20) . Short telomere length, KLRG1 expression, lack of proliferative capacity and high BLIMP-1 expression are all, possibly related, features of the CD161 ++ IL-18Rα + CD8 + T cells that coincide with highly differentiated effector-type CD8 + T cells (18, 20, 34) . On the contrary, CD161 ++ IL-18Rα + CD8 + T cells also express co-stimulatory markers such as CD28 and CD27, highly express CD127 and do not contain effector molecules such as granzyme B, which are all phenotypical characteristics of memory CD8 + T cells (22) .
ALDH is involved in the detoxification of aldehydes, including xenobiotics. HSC and also cancer stem cells highly express ALDH (24) . Cancer stem cells are a subpopulation of tumour cells, which possess stem-cell characteristics and are resistant to chemotherapy (35) . We here demonstrate that CD161 ++ CD8 + T cells do not express higher levels of ALDH. Furthermore, we subsequently analysed the expression of CD24, CD44, CD133 and CD166, which are markers used to identify human cancer stem cells (35, 36) . Besides a slightly higher expression of CD44 on the CD161 + T cells may be evolutionary selected by the high exposure to xenobiotics at sites of inflammation and in the liver and gut. At these sites, there is likely to be more exposure to antigens by which they are constantly triggered. This repeated activation and proliferation may explain their highly differentiated phenotype, as suggested by an increase in KLRG1 expression, high BLIMP-1 expression and telomere erosion.
Supplementary data
Supplementary data are available at International Immunology Online. + T cells (B). DEAB, which blocks ALDH activity, was added as a negative control.
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